Melvin DePamphilis

Dr. Melvin DePamphilis


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Genes & Development
Verified
Journal Article
Closed access
PDF file
ZUZakir Ullah
Zakir Ullah
MKMatthew J. Kohn
Matthew J. Kohn
RYRieko Yagi
Rieko Yagi
LVLyubomir T. Vassilev
Lyubomir T. Vassilev
MDMelvin DePamphilis
Melvin DePamphilis
Genome endoreduplication during mammalian development is a rare event for which the mechanism is unknown. It first appears when fibroblast growth factor 4 (FGF4) deprivation induces differentiation of trophoblast stem (TS) cells into the nonproliferating trophoblast giant (TG) cells required for embryo implantation. Here we show that RO3306 inhibition of cyclin-dependent protein kinase 1 (CDK1), the enzyme required to enter mitosis, induced differentiation of TS cells into TG cells. In contrast, RO3306 induced abortive endoreduplication and apoptosis in embryonic stem cells, revealing that inactivation of CDK1 triggers endoreduplication only in cells programmed to differentiate into polyploid cells. Similarly, FGF4 deprivation resulted in CDK1 inhibition by overexpressing two CDK-specific inhibitors, p57/KIP2 and p21/CIP1. TS cell mutants revealed that p57 was required to trigger endoreduplication by inhibiting CDK1, while p21 suppressed expression of the checkpoint protein kinase CHK1, thereby preventing induction of apoptosis. Furthermore, Cdk2−/− TS cells revealed that CDK2 is required for endoreduplication when CDK1 is inhibited. Expression of p57 in TG cells was restricted to G-phase nuclei to allow CDK activation of S phase. Thus, endoreduplication in TS cells is triggered by p57 inhibition of CDK1 with concomitant suppression of the DNA damage response by p21.


1 June 2006 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
MDMelvin DePamphilis
Melvin DePamphilis
JBJ. Julian Blow
J. Julian Blow
SGSoma Ghosh
Soma Ghosh
TSTapas Saha
Tapas Saha
KNKohji Noguchi
Kohji Noguchi
AVAlex Vassilev
Alex Vassilev

8 March 2019 in Autophagy
Verified
Journal Article
Closed access
GSGaurav Sharma
Gaurav Sharma
CGCarlos Guardia
Carlos Guardia
ARAjit Roy
Ajit Roy
AVAlex Vassilev
Alex Vassilev
ASAmra Saric
Amra Saric
MDMelvin DePamphilis
Melvin DePamphilis
High-throughput screening identified 5 chemical analogs (termed the WX8-family) that disrupted 3 events in lysosome homeostasis: (1) lysosome fission via tubulation without preventing homotypic lys...

28 October 2004 in Cell Cycle
Verified
Journal Article
Closed access
PDF file
MDMelvin DePamphilis
Melvin DePamphilis
The eukaryotic origin recognition complex (ORC) not only selects the sites where pre-replication complexes are assembled and DNA replication begins, it is the first in a series of multiple coherent pathways that determines when pre-replication complexes are assembled. Data from yeast, frogs, flies and mammals present a compelling case that one or more of the six ORC subunits undergoes cell cycle dependent modifications involving phosphorylation and ubiquitination that repress ORC activity during S, G2 and M-phases. ORC activity is not restored until mitosis is complete and a nuclear membrane is present. In yeast, frogs and mammals, the same cyclin-dependent protein kinase [Cdk1(Cdc2)] that initiates mitosis also inhibits assembly of functional ORC/chromatin sites. In yeast, ORC remains bound to chromatin throughout cell division, but in the metazoa either ORC or the Orc1 subunit appears to cycle on and off the chromatin. Thus, this “ORC cycle” is the premier step in preventing re-replication of DNA during a single cell division cycle.

1 June 2009 in Cancer Research
Verified
Journal Article
Closed access
PDF file
WZWenge Zhu
Wenge Zhu
MDMelvin DePamphilis
Melvin DePamphilis
Eukaryotic cells normally restrict genome duplication to once per cell division. In metazoa, re-replication of DNA during a single S phase seems to be prevented solely by suppressing CDT1 activity, a protein required for loading the replicative MCM DNA helicase. However, siRNA suppression of geminin (a specific inhibitor of CDT1) arrested proliferation only of cells derived from cancers by inducing DNA re-replication and DNA damage that spontaneously triggered apoptosis. None of these effects were detected either in cells derived from normal human tissues or in cells immortalized by a viral oncogene. To induce these effects in noncancer cells required suppression of both geminin and cyclin A, another cell cycle regulator. Therefore, initiating DNA replication in some cancer cells is limited solely by regulating the level of CDT1 activity with geminin, whereas noncancer cells contain additional safeguards that prevent DNA re-replication. These results show that inhibition of geminin activity could be used to selectively kill cancer cells without harming other cells. [Cancer Res 2009;69(11):4870–7]